Ad is loading...
IMMX
Price
$2.01
Change
-$0.00 (-0.00%)
Updated
Dec 2 closing price
84 days until earnings call
PRTC
Price
$21.50
Change
-$0.49 (-2.23%)
Updated
Dec 3 closing price
Ad is loading...

IMMX vs PRTC

Header iconIMMX vs PRTC Comparison
Open Charts IMMX vs PRTCBanner chart's image
Immix Biopharma
Price$2.01
Change-$0.00 (-0.00%)
Volume$264.73K
CapitalizationN/A
PureTech Health
Price$21.50
Change-$0.49 (-2.23%)
Volume$689
CapitalizationN/A
IMMX vs PRTC Comparison Chart
Loading...
IMMX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PRTC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
IMMX vs. PRTC commentary
Dec 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMMX is a Buy and PRTC is a StrongBuy.

COMPARISON
Comparison
Dec 04, 2024
Stock price -- (IMMX: $2.24 vs. PRTC: $21.50)
Brand notoriety: IMMX and PRTC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMMX: 149% vs. PRTC: 14%
Market capitalization -- IMMX: $61.62M vs. PRTC: $507.29M
IMMX [@Biotechnology] is valued at $61.62M. PRTC’s [@Biotechnology] market capitalization is $507.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $485.15B to $0. The average market capitalization across the [@Biotechnology] industry is $2.71B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMMX’s FA Score shows that 0 FA rating(s) are green whilePRTC’s FA Score has 1 green FA rating(s).

  • IMMX’s FA Score: 0 green, 5 red.
  • PRTC’s FA Score: 1 green, 4 red.
According to our system of comparison, both IMMX and PRTC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMMX’s TA Score shows that 5 TA indicator(s) are bullish while PRTC’s TA Score has 3 bullish TA indicator(s).

  • IMMX’s TA Score: 5 bullish, 3 bearish.
  • PRTC’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, IMMX is a better buy in the short-term than PRTC.

Price Growth

IMMX (@Biotechnology) experienced а +35.76% price change this week, while PRTC (@Biotechnology) price change was +1.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.35%. For the same industry, the average monthly price growth was -1.83%, and the average quarterly price growth was +8.53%.

Reported Earning Dates

IMMX is expected to report earnings on Feb 26, 2025.

PRTC is expected to report earnings on Nov 27, 2024.

Industries' Descriptions

@Biotechnology (+1.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRTC($507M) has a higher market cap than IMMX($61.6M). PRTC YTD gains are higher at: -23.705 vs. IMMX (-67.630). IMMX has higher annual earnings (EBITDA): -22.41M vs. PRTC (-53.65M). PRTC has more cash in the bank: 502M vs. IMMX (19.7M). IMMX has less debt than PRTC: IMMX (1.09M) vs PRTC (24M). IMMX (0) and PRTC (0) have equivalent revenues.
IMMXPRTCIMMX / PRTC
Capitalization61.6M507M12%
EBITDA-22.41M-53.65M42%
Gain YTD-67.630-23.705285%
P/E RatioN/AN/A-
Revenue00-
Total Cash19.7M502M4%
Total Debt1.09M24M5%
TECHNICAL ANALYSIS
Technical Analysis
IMMXPRTC
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
76%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
71%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
75%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 5 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 1 day ago
80%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
78%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
73%
View a ticker or compare two or three
Ad is loading...
IMMX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PRTC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LGLSX48.590.58
+1.21%
Lord Abbett Growth Leaders R4
IGNAX17.210.15
+0.88%
Delaware Ivy Natural Resources A
PRSRX57.160.04
+0.07%
Putnam Research R
FEBIX13.72-0.01
-0.07%
First Eagle Global Income Builder I
FOVIX33.43-0.20
-0.59%
First Trust/Confluence Small Cap Val I

IMMX and

Correlation & Price change

A.I.dvisor tells us that IMMX and ORMP have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMMX and ORMP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMMX
1D Price
Change %
IMMX100%
+11.44%
ORMP - IMMX
27%
Poorly correlated
-0.20%
PDSB - IMMX
25%
Poorly correlated
+4.65%
VALN - IMMX
24%
Poorly correlated
+0.52%
PRTC - IMMX
24%
Poorly correlated
-2.23%
SRZN - IMMX
23%
Poorly correlated
+0.67%
More

PRTC and

Correlation & Price change

A.I.dvisor tells us that PRTC and RLMD have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRTC and RLMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRTC
1D Price
Change %
PRTC100%
-2.23%
RLMD - PRTC
31%
Poorly correlated
-15.81%
CYTK - PRTC
30%
Poorly correlated
+1.74%
PTCHF - PRTC
29%
Poorly correlated
N/A
ELEV - PRTC
26%
Poorly correlated
-8.57%
IMUX - PRTC
26%
Poorly correlated
-9.29%
More